The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of long-term responders following treatment with talazoparib (TALA) or physician’s choice of chemotherapy (PCT) in the phase 3 embraca trial.
 
Johannes Ettl
Honoraria - AstraZeneca; Celgene; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Tesaro; Teva
Consulting or Advisory Role - Daiichi Sankyo; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Tesaro
Speakers' Bureau - AstraZeneca; Celgene; Lilly; Pfizer; Roche; Teva
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Celgene; Lilly; Novartis; Pfizer; Teva
Other Relationship - Tesaro
 
Hope S. Rugo
Honoraria - Mylan; Puma Biotechnology
Consulting or Advisory Role - Samsung
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo; Macrogenics; Merck; Mylan; Novartis; Pfizer
 
Sara A. Hurvitz
Stock and Other Ownership Interests - Ideal Implant (I); ROM Tech (I)
Research Funding - Ambryx (Inst); Amgen (Inst); Arvinas (Inst); Bayer (Inst); Biomarin (Inst); Cascadian Therapeutics (Inst); Daiichi Sankyo (Inst); Dignitana (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Lilly (Inst); Macrogenics (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Phoenix Molecular Designs (Inst); Pieris Pharmaceuticals (Inst); Puma Biotechnology (Inst); Radius Health (Inst); sanofi (Inst); Seagen (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Lilly
Other Relationship - Pfizer; Roche
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Other Relationship - Novartis; Roche
 
Henri Roche
No Relationships to Disclose
 
Kyung-Hun Lee
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - Surface Oncology
 
Annabel Goodwin
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Tiziana Usari
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Silvana Lanzalone
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Carolin Guenzel
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Joanne Lorraine Blum
Honoraria - Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Genomic Health; Immunomedics; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology; Research to Practice
Consulting or Advisory Role - Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Genomic Health; Immunomedics; Myriad Genetics; Novartis; Pfizer; Puma Biotechnology; Research to Practice
 
Jennifer Keating Litton
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Medivation/Pfizer; Pfizer
Speakers' Bureau - Clinical Care Options; Med Learning Group; Medpage; Medscape; Physicans' Education Resource; Prime Oncology; UpToDate
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Genentech (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Clinical Care Options; Med Learning Group; Medscape; Physicans' Education Resource
Other Relationship - Medivation/Pfizer